ASIA PHARMA EXPO 2025 - 16th International Exhibition on COMPLETE Pharma Manufacturing

The 16th ASIA PHARMA EXPO 2025 (APE 2025), an international exhibition on COMPLETE pharma manufacturing technologies focusing the South Asian pharmaceutical industries scheduled during February 12 to 14, 2025 at Bangabandhu Bangladesh-China Friendship Exhibition Center (BBCFEC), Purbachal, Dhaka, Bangladesh. This will provide networking platforms for participants and highly resourceful and beneficial for the regional pharmaceutical and chemical manufacturing fraternity.

Date：February 12 to 14, 2025

Venue：Bangladesh China Friendship Exhibition Center (BCFEC), Purbachal, Dhaka, BANGLADESH

Exhibition Scale：

800+ Expected Exhibiting Companies

32+ Expected Countries

14,500+ Expected Attendees

2,35,000+ Sq. Ft. Floor Area

Exhibitor Profile：

PROCESSING Machineries (Tablet / Capsule / Injectable / Ointment / Powder - Dry Syrup)

PACKAGING Machineries & Materials (Blister Machines, Filling / Packing / Labeling / Capping Machines, Labels, Aluminum / PVC Foils, Caps / Closures / Rubber Stoppers, and many more)

API Manufacturing Plants & Equipments

API, Pharma Bulk Actives, Excipients, Additives

FORMULATIONS

Contract Manufacturing

CLEANROOM & Utility Eqpts & Services (HVAC, Partitions, AHU, Dehumidifiers)

WATER TREATMENT & Management Systems (CIP / SIP, Filtration / Sterilization Plants)

PROJECT Consultants

TURNKEY Contractors

Trade ASSOCIATIONS & many more

Visitor Profile：

CEO & Top Management

Corporate Management

Drug REGULATORY Authorities

Manufacturing / Production officers

QA, QC and Research

Pharmacists

Contract Manufacturers

Plant Management

Plant Engineering

Maintenance Engineering

Vender Development & Purchaseg

Compliance & Regulatory

Warehousing & Supply Chain

Equipment, Machinery Manufacture, Suppliers & Distributors

Drug Stores, API & Formulation Importers

Why Participate?

One of the fastest growing pharma economy of the world

The rapid growth rate to meet the Demand & Supply statistics of Bangladesh has attracted the global attention

Over-all growth rate of the Bangladesh pharma industry: 18%

No. of pharma manufacturing facilities more than 340

With the highest exports of the formulation, Bangladesh offers all the advantages for its strategic location in the South Asian pharma region

Based on WTO meet / Doha declaration, Bangladesh will able to produce drugs which are still under Patent protection until year 2033

Organizer - BAPI Profile：

Bangladesh Association of Pharmaceutical Industries (BAPI) was established in 1972 with 33 member pharmaceutical companies. Today, BAPI has as good as 149 pharmaceutical companies as its members. BAPI is the one and only registered and recognized association of the private sector pharmaceutical companies of Bangladesh. BAPI has been enrolled as member of International Federation of Pharmaceutical Manufacturers Association (IFPMA), Geneva. Though its major activities include upholding interests of the pharmaceutical manufacturers of Bangladesh to the relevant forums, in last few years BAPI also organized various health awareness programs, campaigns, against spurious drugs, export potentials & problems in Bangladesh etc. In 2003, BAPI organized "ASIA PHARMA EXPO-2003" – one of the major pharma event/exhibition held in this region. In 2005, once again, BAPI organized "ASIA PHARMA EXPO 2005" – which attracted most of the largest stake – holders of pharma and associated industry of Asia & Europe. Apart from these events and campaign programs, BAPI is also involved in various social activities, like donation of medicines to various hospitals, flood-affected people, cyclone relied fund both home & abroad.

In Bangladesh, Pharmaceutical is one of the fastest growing sectors. In 2004, the total size of the pharma market of Bangladesh was estimated to be Taka 30,000 million with an annual growth rate of about 10%. The pharma industry in Bangladesh is paying the second largest revenue to the Government's exchequer. BAPI's member firms are meeting 97% of the total demand of pharmaceuticals. Besides catering to local demand Bangladesh is also exporting its formulations to 62 countries of the world and demand for export is increasing rapidly. Bangladesh Pharmaceutical Industry is now heading towards self – sufficiency in pharmaceuticals.

The Bangladesh pharma industry grew 12 to 15% last year and 1,500 medicines have been registered worldwide. In the current situation of LDC graduation period, Bangladesh pharma industry is offering medicines at very negligible cost bypassing the royalty fees. If the government gives registration of patented drugs before LDC graduation, the royalty fees can be escaped. 

Bangladesh pharma manufacturing industry:

The pharmaceutical sector of Bangladesh is progressing multifold. Apart from meeting the domestic demands of pharma formulations, the pharma industry is also earning huge foreign exchange from the exports. With the existing market value of about USD 3 billion, the Bangladesh pharma manufacturing industry is rapidly marching ahead with great potential as 98% of the country’s total demand for medicine is being met by nearly 300 domestic manufacturers, which is a milestone in the history of the Bangladesh pharmaceutical industry. At the same time, these local manufacturers are exporting as well to more than 142 countries across the world.

The anticipated market size of the Bangladesh pharmaceutical industry is more than USD 6 billion by 2025 with an absolute growth of 114% from 2019 levels, while the pharma exports of Bangladesh is likely to cross USD 450 Million by 2025. The share of the local manufacturing companies is above 90%.

An encouraging development is more than 47 units at API Manufacturing Park are coming up near Dhaka. The Bangladesh pharma industry now meets around 98% of the local demand for medicines, which is a milestone in the history of the pharmaceutical industry.

Contact Details:

WhatsApp: +1 555 709 4905

Email: [email protected]

Website: https://asiapharma.org/ape/index.php